- Glaxo to Close Italy R&D Center, Affecting 500 Jobs, Unions Say (Bloomberg)
- QIAGEN Unit and Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients (MarketWatch)
- PREVIEW-Sanofi Q4 Seen Up, Cautious for 2010 (Reuters)
- EC Changes on Running Pharma Must Not be Cosmetic – DTB (PharmaTimes)
- FDA Sends Letter to Eli Lilly Regarding Promotions for Adcirca (PharmaLive)
- First Health 2.0 Europe Conference to be Held in Paris (World Pharma News)
- Roche Enters Into Major Stem Cell Pact (PharmaTimes)
- For Tough 2010, Pharma Cuts Billions From R&D (FiercePharma)
- BioMarin Bags PARP Inhibitor with Lead Therapeutics Buy (PharmaTimes)
- FDA Compares Dissolvable Tobacco to Candy (Msnbc)
- DxS Enters Pact With Pfizer (Pharmaceutical Business Review)
SUBSCRIBE